See also this year's filing and all EDGAR filings for this company.
PDF Report 0001498382_2020_Tuhura_Biosciences_Inc_NV.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -9198000} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 2.0, 'aggregate_val': -9198000, 'exp_sum': 9198000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 4514000, 'ResearchAndDevelopmentExpense': 3630000, 'remainder_Expenses': 1054000}} |
Graph
Absolute values for 0001498382, Tuhura Biosciences Inc NV
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,025,193 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 12,062 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 0 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,069,725 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,736,440 |
| 9 | ResearchAndDevelopmentExpense | 3,662,056 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 350,275 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,037,255 |
| 1 | Liabilities | 2,069,725 |
| 2 | Expenses | 8,398,496 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,967,530 |
| 5 | NetIncome | -8,048,221 |
| 6 | ComprehensiveNetIncome | -8,048,221 |
| 7 | BaseVar | 7,427,876 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.23 |
| 9 | EconomicCapitalRatio | 1.25 |
Edgar->Model Mapping
Feature Distribution
Change over Time
